4C4H
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04-1 |
Synchrotron site | Diamond |
Beamline | I04-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2011-05-23 |
Detector | DECTRIS PILATUS |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 69.670, 104.690, 111.780 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 58.000 - 2.800 |
R-factor | 0.1987 |
Rwork | 0.197 |
R-free | 0.24110 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4bi1 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.140 |
Data reduction software | MOSFLM |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.4) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 58.000 | 2.950 |
High resolution limit [Å] | 2.800 | 2.800 |
Rmerge | 0.050 | 0.480 |
Number of reflections | 9139 | |
<I/σ(I)> | 13.5 | 2 |
Completeness [%] | 88.8 | 83.1 |
Redundancy | 3.7 | 3.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 7.5 | 30-35% AQUEOUS PEG300 ONLY, pH 7.5 |